Penumbra Inc (PEN)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$268.01

Buy

$268.50

arrow-up$1.755 (+0.66%)

Prices updated at 18 Feb 2025, 17:43 EST
| Prices minimum 15 mins delay
|
Prices in USD

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.

Profit margins

Created with Highcharts 7.2.2Gross margin (%)Operating margin (%)EBITDA margin (%)Net margin (%)20192020202120222023-250255075

Valuation

Created with Highcharts 7.2.2Price earningsPrice / SalesPrice / Cash flow202120222023202420250200400600800

Profit margins data table

Gross margin (%)
202364.49
202263.18
202163.59
202060.34
201967.95
201865.75
201765.06
201664.88

Valuation data table

Price / Sales
20258.97
20247.93
20239.83
202210.19
202115.08
202011.62
201911.85
201810.55
201710.00
20167.97
20159.62
Price/Forward earnings (YTD)
71.94

Returns

Created with Highcharts 7.2.2Return on assets (%)Return on equity (%)Return on invested capital (%)20192020202120222023-5051015

Debt profile

Created with Highcharts 7.2.2Financial leverage2019202020212022202300.511.5

Returns data table

Return on assets (%)
20236.21
2022-0.15
20210.51
2020-2.11
20198.21
20181.33
20171.19
20165.18

Debt profile data table

YearFinancial leverage
20231.32
20221.37
20211.30
20201.28
20191.37
20181.22
20171.19
20161.16
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.